MicroPort CardioFlow Medtech Corporation (HKG:2160)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.490
+0.020 (0.81%)
Apr 29, 2026, 3:59 PM HKT
-44.67%
Market Cap 3.15B
Revenue (ttm) 444.00M
Net Income (ttm) -146.48M
Shares Out 1.27B
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 923,600
Average Volume 1,737,775
Open 2.490
Previous Close 2.470
Day's Range 2.440 - 2.530
52-Week Range 2.440 - 8.450
Beta 0.45
RSI 32.78
Earnings Date May 28, 2026

About HKG:2160

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, tran... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Employees 417
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2160
Full Company Profile

Financial Performance

In 2025, HKG:2160's revenue was $57.04 million, an increase of 15.16% compared to the previous year's $49.54 million. Losses were -$18.82 million, 177.8% more than in 2024.

Financial numbers in USD Financial Statements

News

There is no news available yet.